Initial clinical characteristics of patients with UCD and iMCD
. | UCD . | iMCD . | P value . | ||
---|---|---|---|---|---|
No. of patients . | N (%) of patients* or median no. of cells# . | No. of patients . | n (%) of patients* or median no. of cells# . | ||
WBC count (×109/L) | 32 | 30 | |||
<4 | 2 (6.25)* | 5 (16.66)* | .249 | ||
>10 | 2 (6.25)* | 4 (13.33)* | .418 | ||
Hemoglobin (g/L) | 32 | 30 | |||
<12 g/L | 4 (12.5)* | 12 (40.0)* | .002 | ||
Platelets (×109/L) | 32 | 30 | |||
<150 | 0 (0)* | 5 (16.67)* | .052 | ||
150-300 | 23 (71.87)* | 14 (46.67)* | .069 | ||
>300 | 9 (28.13)* | 12 (40.0)* | .422 | ||
Lymphocyte count (× 109/L) | 31 | 1.46 ± 0.94# | 27 | 1.43 ± 0.75# | .916 |
Leukocyte count (× 109/L) | 31 | 4.19 ± 1.86# | 30 | 4.61 ± 2.86# | .443 |
Hypoalbuminemia (mg/L) | 37 | 2 (5.41)* | 24 | 4 (16.66)* | .200 |
Elevation of serum LDH (IU/L) | 37 | 4 (10.81)* | 29 | 4 (13.79)* | .723 |
Elevation of serum β2-MG level (mg/L) | 30 | 3 (10.00)* | 28 | 16 (57.14)* | .000 |
Elevation of serum AKP (IU/L) | 36 | 3 (8.33)* | 29 | 10 (34.48)* | .013 |
Elevation of serum ESR (mm/h) | 16 | 3 (18.75)* | 17 | 9 (52.94)* | .033 |
IgA > 499 mg/L | 17 | 0 (0)* | 19 | 6 (31.58)* | .020 |
IgG > 1616 mg/L | 17 | 1 (5.88)* | 20 | 7 (35.0)* | .048 |
IgM > 242 mg/L | 16 | 1 (6.25)* | 19 | 1 (5.26)* | 1.000 |
Solitary mass > 5 cm | 43 | 15 (34.88)* | 31 | 6 (19.35)* | .194 |
Max SUV of lymph node | 11 | 3.91 ± 1.33# | 12 | 4.63 ± 1.02# | .156 |
. | UCD . | iMCD . | P value . | ||
---|---|---|---|---|---|
No. of patients . | N (%) of patients* or median no. of cells# . | No. of patients . | n (%) of patients* or median no. of cells# . | ||
WBC count (×109/L) | 32 | 30 | |||
<4 | 2 (6.25)* | 5 (16.66)* | .249 | ||
>10 | 2 (6.25)* | 4 (13.33)* | .418 | ||
Hemoglobin (g/L) | 32 | 30 | |||
<12 g/L | 4 (12.5)* | 12 (40.0)* | .002 | ||
Platelets (×109/L) | 32 | 30 | |||
<150 | 0 (0)* | 5 (16.67)* | .052 | ||
150-300 | 23 (71.87)* | 14 (46.67)* | .069 | ||
>300 | 9 (28.13)* | 12 (40.0)* | .422 | ||
Lymphocyte count (× 109/L) | 31 | 1.46 ± 0.94# | 27 | 1.43 ± 0.75# | .916 |
Leukocyte count (× 109/L) | 31 | 4.19 ± 1.86# | 30 | 4.61 ± 2.86# | .443 |
Hypoalbuminemia (mg/L) | 37 | 2 (5.41)* | 24 | 4 (16.66)* | .200 |
Elevation of serum LDH (IU/L) | 37 | 4 (10.81)* | 29 | 4 (13.79)* | .723 |
Elevation of serum β2-MG level (mg/L) | 30 | 3 (10.00)* | 28 | 16 (57.14)* | .000 |
Elevation of serum AKP (IU/L) | 36 | 3 (8.33)* | 29 | 10 (34.48)* | .013 |
Elevation of serum ESR (mm/h) | 16 | 3 (18.75)* | 17 | 9 (52.94)* | .033 |
IgA > 499 mg/L | 17 | 0 (0)* | 19 | 6 (31.58)* | .020 |
IgG > 1616 mg/L | 17 | 1 (5.88)* | 20 | 7 (35.0)* | .048 |
IgM > 242 mg/L | 16 | 1 (6.25)* | 19 | 1 (5.26)* | 1.000 |
Solitary mass > 5 cm | 43 | 15 (34.88)* | 31 | 6 (19.35)* | .194 |
Max SUV of lymph node | 11 | 3.91 ± 1.33# | 12 | 4.63 ± 1.02# | .156 |